Category: Federal Forum Posters
Purpose: The Miami Veterans Affairs Medical Center’s pharmacy service recently incorporated osteoporosis as a new disease state that will be managed in pharmacist-led medication management patient aligned care team clinics. Primary literature has shown that osteoporosis management by clinical pharmacy specialists has improved therapeutic outcomes. Our objective is to evaluate the impact of clinical pharmacy specialists dedicated to the management of osteoporosis compared to patients managed by other health care providers within the veteran population.
Methods: A retrospective analysis will be conducted on patients managed by clinical pharmacy specialists following a diagnosis, by bone mineral density scan, of osteoporosis or osteopenia with a high FRAX score (a 10-year hip fracture probability at or greater than 3 percent or major osteoporosis-related fracture probability at or greater than 20 percent). After bone mineral density scans were read by endocrinology, the ordering provider had 30 days in which to initiate pharmacologic therapy, if indicated. If no action had been taken by the ordering provider after 30 days, then clinical pharmacy specialists initiated pharmacologic therapy and monitored these patients throughout the duration of therapy for up to one year. This analysis will evaluate the impact of these pharmacist-led interventions. Variables to be assessed include: appropriateness of medication management based on the 2013 National Osteoporosis Foundation guidelines, follow up care at months 1, 3, 6, and 12, medication compliance, concomitant disease states and medications, fracture risk assessment, and rate of fractures.
Results: Not applicable
Conclusion: Not applicable
Melissa Martin– PGY1 Pharmacy Resident, Miami VA Healthcare System, Miami, FL